Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study

Figure 10

Overall Quality of Life (QoL) in PIPAC patients (Lausanne cohort) as compared with the general population. Overall QoL was compared by use of EORTC QLQ-C30 [14] for the Lausanne PIPAC cohort versus a European cohort of 16,151 healthy citizens (general population). The control group had a slightly better QoL score that was statistically significant but of small clinical relevance (<10%) according to Osoba et al. [15].